Dial back drug-pricing

Democrats dial back drug-pricing plans to win over moderates It’s a sign the drug industry is bending a potential compromise in manufacturers’ favor after spending more than $171 million lobbying in the first half of this year. By ALICE MIRANDA OLLSTEIN and MEGAN WILSON Top congressional Democrats are acknowledging for the first time that they’ll have to scale back their drug pricing plans to win centrist votes for their giant social spending package.

Read the source article at A Day in the Life of the Universe
2021-09-30 15:05:00